SwePub
Sök i LIBRIS databas

  Extended search

id:"swepub:oai:DiVA.org:su-170219"
 

Search: id:"swepub:oai:DiVA.org:su-170219" > BRL37344 stimulates...

  • 1 of 1
  • Previous record
  • Next record
  •    To hitlist

BRL37344 stimulates GLUT4 translocation and glucose uptake in skeletal muscle via beta(2)-adrenoceptors without causing classical receptor desensitization

Mukaida, Saori (author)
Sato, Masaaki (author)
Öberg, Anette I. (author)
Stockholms universitet,Institutionen för molekylär biovetenskap, Wenner-Grens institut
show more...
Dehvari, Nodi (author)
Stockholms universitet,Institutionen för molekylär biovetenskap, Wenner-Grens institut
Olsen, Jessica M. (author)
Stockholms universitet,Institutionen för molekylär biovetenskap, Wenner-Grens institut
Kocan, Martina (author)
Halls, Michelle Louise (author)
Merlin, Jon (author)
Sandström, Anna L. (author)
Stockholms universitet,Institutionen för molekylär biovetenskap, Wenner-Grens institut
Csikasz, Robert (author)
Stockholms universitet,Institutionen för molekylär biovetenskap, Wenner-Grens institut
Evans, Bronwyn Anne (author)
Summers, Roger James (author)
Hutchinson, Ana Sabine (author)
Bengtsson, Tore (author)
Stockholms universitet,Institutionen för molekylär biovetenskap, Wenner-Grens institut
show less...
 (creator_code:org_t)
American Physiological Society, 2019
2019
English.
In: American Journal of Physiology. Regulatory Integrative and Comparative Physiology. - : American Physiological Society. - 0363-6119 .- 1522-1490. ; 316:5, s. R666-R677
  • Journal article (peer-reviewed)
Abstract Subject headings
Close  
  • The type 2 diabetes epidemic makes it important to find insulinin-dependent ways to improve glucose homeostasis. This study examines the mechanisms activated by a dual beta(2)-/beta(3)-adrenoceptor agonist, BRL37344, to increase glucose uptake in skeletal muscle and its effects on glucose homeostasis in vivo. We measured the effect of BRL37344 on glucose uptake, glucose transporter 4 (GLUT4) translocation, cAMP levels, beta(2)-adrenoceptor desensitization, beta-arrestin recruitment, Akt, AMPK, and mammalian target of rapamycin (mTOR) phosphorylation using L6 skeletal muscle cells as a model. We further tested the ability of BRL37344 to modulate skeletal muscle glucose metabolism in animal models (glucose tolerance tests and in vivo and ex vivo skeletal muscle glucose uptake). In L6 cells, BRL37344 increased GLUT4 translocation and glucose uptake only by activation of beta(2)-adrenoceptors, with a similar potency and efficacy to that of the nonselective beta-adrenoceptor agonist isoprenaline, despite being a partial agonist with respect to cAMP generation. GLUT4 translocation occurred independently of Akt and AMPK phosphorylation but was dependent on mTORC2. Furthermore, in contrast to isoprenaline, BRL37344 did not promote agonist-mediated desensitization and failed to recruit beta-arrestin1/2 to the beta(2)-adrenoceptor. In conclusion, BRL37344 improved glucose tolerance and increased glucose uptake into skeletal muscle in vivo and ex vivo through a beta(2)-adrenoceptor-mediated mechanism independently of Akt. BRL37344 was a partial agonist with respect to cAMP, but a full agonist for glucose uptake, and importantly did not cause classical receptor desensitization or internalization of the receptor.

Subject headings

NATURVETENSKAP  -- Biologi (hsv//swe)
NATURAL SCIENCES  -- Biological Sciences (hsv//eng)

Keyword

beta(2)-adrenoceptor
beta-arrestin
BRL37344
glucose uptake
GLUT4
isoprenaline
receptor desensitization
skeletal muscle

Publication and Content Type

ref (subject category)
art (subject category)

Find in a library

To the university's database

  • 1 of 1
  • Previous record
  • Next record
  •    To hitlist

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.

 
pil uppåt Close

Copy and save the link in order to return to this view